Adenosine Injection, 6mg/2ml (3mg/ml) Vial
Product Images NDC 51662-1201

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Adenosine Injection, 6mg/2ml (3mg/ml) Vial (NDC 51662-1201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co. Llc, Dba Health First, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adenosine Flag Label (20180711 Hf Adenosine Glint Flag Label 1 July 11 Update Resized)

Adenosine Flag Label (20180711 Hf Adenosine Glint Flag Label 1 July 11 Update Resized)
This appears to be a label or packaging for a medical device or medication. It includes a product code (10), a location (Mukilteo, WA), and a warning that the product is only available by prescription (RX ONLY). However, without additional information or context, it is not clear what specific product this label is attached to.*
FDA Label Image

5166212012 Label

5166212012 Label
Adenosine Injection is a solution for rapid bolus intravenous use that comes in a 6mg/2mL (3mg/mL) single-use vial. This medication does not contain any preservatives and any unused portion after opening should be discarded. It is essential to keep the injection away from children and at a specific storage temperature range of 20 to 25C (68 to 77F) to avoid crystalization. However, if the solution crystallizes, it can be dissolved by warming to room temperature. The manufacturer's instruction should be followed closely, and the solution must be clear and particle-free while in use. The Lot and Expiration date for this particular product are ABCDEFGHIJKLMNOPQRST and 2021-06-01, respectively. The National Drug Code (NDC) for this injection is 51662-1201-2, and the Original Manufacturer's NDC is 17478-542-02. This medication is available only by prescription, and HF Acquisition Co., LLC distributes it.*
FDA Label Image

5166212013 Rfid Label

FDA Label Image

5166212013 Label

5166212013 Label
Adenosine Injection, USP is a solution used for rapid intravenous administration without any preservatives. The solution should be kept out of reach of children and should be discarded if unused. It should be stored at room temperature (20 to 25°C) and must not be refrigerated as it can cause crystalization. In case of crystalization, the solution should be warmed to room temperature until the crystals are dissolved. The solution must be clear and free from particles at the time of use. The manufacturer’s package insert should be referred to for detailed information. The product is distributed by HF Acquisition Co., LLC, and has the NDC code 51662-1201-3. The lot number is ABCDEFGHIJKLMNOPGQRST and the expiry date is 2021-06-01.*
FDA Label Image

Anenosine Container Label (Adenosine Container Label)

Anenosine Container Label (Adenosine Container Label)
This is a description of a medication called Adenosine. It is an injection that is used intravenously for rapid bolus treatment. The text contains various alphanumeric codes, but no substantial information about side effects or indications for use.*
FDA Label Image

Structural Formula (Adenosine)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.